Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study

International Journal of Cancer - Tập 138 Số 12 - Trang 2867-2874 - 2016
Eva Herweijer1, Karin Sundström2, Alexander Ploner1, Ingrid Uhnoo3, Pär Sparén1, Lisen Arnheim‐Dahlström1
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
2Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
3Department of Monitoring and Evaluation, Public Health Agency of Sweden, Sweden

Tóm tắt

Human papillomavirus (HPV) types 16/18, included in HPV vaccines, contribute to the majority of cervical cancer, and a substantial proportion of cervical intraepithelial neoplasia (CIN) grades 2/3 or worse (CIN2+/CIN3+) including adenocarcinoma in situ or worse. The aim of this study was to quantify the effect of quadrivalent HPV (qHPV) vaccination on incidence of CIN2+ and CIN3+. A nationwide cohort of girls and young women resident in Sweden 2006–2013 and aged 13–29 (n = 1,333,691) was followed for vaccination and histologically confirmed high‐grade cervical lesions. Data were collected using the Swedish nationwide healthcare registers. Poisson regression was used to calculate incidence rate ratios (IRRs) and vaccine effectiveness [(1‐IRR)x100%] comparing fully vaccinated with unvaccinated individuals. IRRs were adjusted for attained age and parental education, and stratified on vaccination initiation age. Effectiveness against CIN2+ was 75% (IRR = 0.25, 95%CI = 0.18–0.35) for those initiating vaccination before age 17, and 46% (IRR = 0.54, 95%CI = 0.46–0.64) and 22% (IRR = 0.78, 95%CI = 0.65–0.93) for those initiating vaccination at ages 17–19, and at ages 20–29, respectively. Vaccine effectiveness against CIN3+ was similar to vaccine effectiveness against CIN2+. Results were robust for both women participating to the organized screening program and for women at prescreening ages. We show high effectiveness of qHPV vaccination on CIN2+ and CIN3+ lesions, with greater effectiveness observed in girls younger at vaccination initiation. Continued monitoring of impact of HPV vaccination in the population is needed in order to evaluate both long‐term vaccine effectiveness and to evaluate whether the vaccination program achieves anticipated effects in prevention of invasive cervical cancer.

Từ khóa


Tài liệu tham khảo

BruniL Barrionuevo‐RosasL SerranoB et al. Human Papillomavirus and Related Diseases in the World. Summary Report 2014‐08‐22. ICO Information Centre on HPV and Cancer (HPV Information Centre).

10.1038/bjc.2014.362

10.1016/j.vaccine.2006.05.026

10.1002/ijc.20244

10.1002/ijc.27485

10.1016/j.ygyno.2011.10.020

10.1038/sj.bjc.6605165

NKCx [Internet]. Available at:http://www.nkcx.se/index_e.htm. (Accessed on July 1 2015).

Greer CE, 1995, Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus‐like particles in patients with genital warts, J Clin Microbiol, 33, 2058, 10.1128/jcm.33.8.2058-2063.1995

10.1086/597071

PowerPoint Presentation—HPV_vaccination_tom_14‐12‐31.pdf. Available at:http://www.folkhalsomyndigheten.se/documents/smittskydd-sjukdomar/vaccinationer/HPV_vaccination_tom_14-12-31.pdf. (Accessed on July 1 2015).

10.1093/jnci/djt460

10.1186/1741-7015-11-227

10.1200/JCO.2013.52.4645

10.1016/j.vaccine.2012.10.092

10.1136/bmj.g1458

10.1080/02841860802247664

Swedish Cancer Registry. Available at: about:reader?url=http%3A%2F%2Fwww.socialstyrelsen.se%2Fregister%2Fhalsodataregister%2Fcancerregistret%2Finenglish. (Accessed on June 5 2015)

Läkemedelsregistret [Internet]. Available at:http://www.socialstyrelsen.se/register/halsodataregister/lakemedelsregistret. (Accessed on June 24 2015).

10.1093/jnci/djt032

10.1001/jama.298.7.743

10.1002/ijc.25940

10.1016/j.vaccine.2015.01.084

10.1086/524875

Castellsagué X, 2014, Risk of first cervical HPV infection and pre‐cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial, BMC Infect Dis, 14, 551, 10.1186/s12879-014-0551-y

10.1111/j.1600-0412.2010.01066.x

10.1371/journal.pone.0134185

Thông tin
Thông tin xuất bản

International Journal of Cancer

Tập 138 Số 12

2867-2874

Thông tin tác giả